Lupin Launches Generic Clobetasol Cream in the US

Thursday, August 23, 2018 | FDA Approval/Clearance , Pediatric , Psoriasis , Product Launches and Updates


Lupin has launched its Clobetasol Propionate Cream 0.05%, having received approval from the FDA earlier.
Lupin's Clobetasol Propionate Cream USP 0.05% is the generic equivalent of Fougera Pharmaceuticals Inc.'s Temovate® Cream, 0.05%. It is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Clobetasol Propionate Cream USP 0.05% had annual sales of approximately USD 108.6 million in the US (IQVIA MAT June 2018), according to data cited by Lupin.
 

Next Story

Comments

You must be logged in to leave a comment.